RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+23.63%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.11B
AUM Growth
+$1.11B
(+21%)
Cap. Flow
+$85.8M
Cap. Flow
% of AUM
7.7%
Top 10 Holdings %
Top 10 Hldgs %
48.19%
Holding
72
New
18
Increased
12
Reduced
16
Closed
18
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$53.2M |
| 2 |
ENDP
Endo International plc
ENDP
|
$50.3M |
| 3 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$41.9M |
| 4 |
ALR
Alere Inc
ALR
|
$32.5M |
| 5 |
Biogen
BIIB
|
$23.1M |
Top Sells
| 1 |
RAD
Rite Aid Corporation
RAD
|
$45.4M |
| 2 |
CELG
Celgene Corp
CELG
|
$38.3M |
| 3 |
Gilead Sciences
GILD
|
$34.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$25.3M |
| 5 |
AstraZeneca
AZN
|
$18.2M |
Sector Composition
| 1 | Healthcare | 81.12% |
| 2 | Financials | 2.03% |
| 3 | Technology | 1.63% |
| 4 | Communication Services | 1.57% |
| 5 | Consumer Staples | 1.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $96.7M | 8.69% | 13,125,594 +1,267,300 | +11% | +$9.34M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $66.9M | 6% | 900,879 +179,247 | +25% | +$13.3M |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $63.5M | 5.7% | 5,832,228 -1,043,046 | -15% | -$11.3M |
|
4
Bausch Health
BHC
$2.74B
| $53.3M | 4.79% | 268,519 -69,958 | -21% | -$13.9M |
|
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $53.2M | 4.78% | +853,973 | New | +$53.2M |
|
|
ENDP
6
DELISTED
Endo International plc
ENDP
| $50.3M | 4.51% | +560,443 | New | +$50.3M |
|
|
ASPX
7
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $41.9M | 3.76% | +417,533 | New | +$41.9M |
|
|
8
Biogen
BIIB
$19.4B
| $41.3M | 3.7% | 97,713 +54,600 | +127% | +$23.1M |
|
|
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
| $37.2M | 3.34% | 1,052,666 +68,700 | +7% | +$2.43M |
|
|
ALR
10
DELISTED
Alere Inc
ALR
| $32.5M | 2.92% | +664,138 | New | +$32.5M |
|
|
CMRX
11
DELISTED
Chimerix, Inc.
CMRX
| $31.8M | 2.86% | 844,456 -312,728 | -27% | -$11.8M |
|
12
Insmed
INSM
$28.8B
| $28.7M | 2.58% | 1,381,828 +369,457 | +36% | +$7.68M |
|
|
RCPT
13
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $26.3M | 2.36% | 159,413 -153,323 | -49% | -$25.3M |
|
14
Standard BioTools
LAB
$481M
| $23.7M | 2.13% | 562,437 -48,005 | -8% | -$2.02M |
|
|
AET
15
DELISTED
Aetna Inc
AET
| $22.6M | 2.03% | +211,974 | New | +$22.6M |
|
16
DaVita
DVA
$9.85B
| $21.6M | 1.94% | +265,858 | New | +$21.6M |
|
|
TVTY
17
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $21.2M | 1.9% | 1,074,033 +5,544 | +0.5% | +$109K |
|
18
Ultragenyx Pharmaceutical
RARE
$2.89B
| $20.7M | 1.85% | +332,600 | New | +$20.7M |
|
|
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $19.9M | 1.79% | 1,415,482 +344,487 | +32% | +$4.85M |
|
|
CIVI
20
DELISTED
Civitas Solutions, Inc.
CIVI
| $18.4M | 1.65% | 879,485 | – | – |
|
|
CSLT
21
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $18.1M | 1.63% | 2,336,498 +1,089,230 | +87% | +$8.45M |
|
|
MODN
22
DELISTED
MODEL N, INC.
MODN
| $17.5M | 1.57% | 1,461,678 | – | – |
|
23
Jazz Pharmaceuticals
JAZZ
$7.75B
| $17.3M | 1.55% | +100,000 | New | +$17.3M |
|
|
ZSPH
24
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $17.1M | 1.53% | 405,688 -119,014 | -23% | -$5.01M |
|
25
Adverum Biotechnologies
ADVM
$64.6M
| $17.1M | 1.53% | 421,133 -277,937 | -40% | -$11.3M |
|